[Positron emission tomography (PET) and (F-18)-fluorodeoxyglucose in (FDG) in cancerology]

Autor: Maublant J, Jp, Vuillez, jean-noel talbot, Lumbroso J, Jp, Muratet, Jy, Herry, Jc, Artus

Publikováno v: Europe PubMed Central

Positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) is a scintigraphic imaging technique undergoing a rapid growth in the field of oncology. The constant progress of the detectors, either CDET or PET dedicated cameras, allows to obta

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::40720df9d29a0664466a3e0303ec633c
https://pubmed.ncbi.nlm.nih.gov/9951421

Potential use of radiolabeled antisense oligonucleotides in oncology

Autor: As, Gauchez, Amaury du MOULINET d'HARDEMARE, Lunardi J, Jp, Vuillez, Fagret D

Publikováno v: Europe PubMed Central

Antisense oligodeoxynucleotides (ODNs) have great promise for therapy. Oligomers labeled with gamma-emitting radioelements have great promise for diagnosis. These radiolabeled oligomers can be used to identify the presence of a particular messenger R

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::8678139d5d19ce5220f9b32a78dfda71
http://europepmc.org/abstract/med/10697501

[Tumor necrosis factor during the course of neuromalaria: new therapeutic perspectives]

Autor: Stephane Picot, Peyron F, Jp, Vuillez, Barbe G, Ambroise-Thomas P

Publikováno v: Europe PubMed Central

Malaria remains one of the major public health problem in tropical and subtropical world. Malaria pathogeny depends partly on parasite multiplication and partly on some elements of the immunological response. It has recently become evident that one o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d00b8fc6603b2deb64338fc15498ed34
http://europepmc.org/abstract/med/1819397

Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody

Autor: Barbet J, Peltier P, Bardet S, Jp, Vuillez, Bachelot I, Denet S, Olivier P, Leccia F, Corcuff B, Damien Huglo, Proye C, Rouvier E, Meyer P, Jf, Chatal

Publikováno v: Europe PubMed Central

Pretargeting labeled bivalent hapten with bispecific antibodies has proven feasible in the clinic, and our earlier results have suggested the technique may be very sensitive for detecting small recurrences and metastases. Medullary thyroid carcinoma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::7a750d49081b049f8b881f87c6f97397
http://europepmc.org/abstract/med/9669389

Development and Validation of Analytical Methods for Radiochemical Purity of ¹⁷⁷ Lu-PSMA-1.

Autor: Orhon P; Pharmacy Department, Grenoble Alpes University Hospital, 38000 Grenoble, France., Desruet MD; Pharmacy Department, Grenoble Alpes University Hospital, 38000 Grenoble, France.; LRB, CHU Grenoble Alpes, INSERM, Grenoble Alpes University, 38000 Grenoble, France., Piquemal M; Pharmacy Department, Grenoble Alpes University Hospital, 38000 Grenoble, France., De Leiris N; LRB, CHU Grenoble Alpes, INSERM, Grenoble Alpes University, 38000 Grenoble, France.; Nuclear Medicine, Grenoble Alpes University Hospital, 38000 Grenoble, France., Djaileb L; LRB, CHU Grenoble Alpes, INSERM, Grenoble Alpes University, 38000 Grenoble, France.; Nuclear Medicine, Grenoble Alpes University Hospital, 38000 Grenoble, France., Vuillez JP; LRB, CHU Grenoble Alpes, INSERM, Grenoble Alpes University, 38000 Grenoble, France.; Nuclear Medicine, Grenoble Alpes University Hospital, 38000 Grenoble, France., Bedouch P; Pharmacy Department, Grenoble Alpes University Hospital, 38000 Grenoble, France.; TIMC-IMAG, UMR 5525, CNRS, Grenoble Alpes University, 38000 Grenoble, France., Leenhardt J; Pharmacy Department, Grenoble Alpes University Hospital, 38000 Grenoble, France.; LRB, CHU Grenoble Alpes, INSERM, Grenoble Alpes University, 38000 Grenoble, France.

Publikováno v: Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2022 Apr 24; Vol. 15 (5). Date of Electronic Publication: 2022 Apr 24.